Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Alzheimer's Disease

Free Subscription Articles published in Science Retrieve available abstracts of 44 articles: HTML format

Single Articles

June 2024
1. PARK J, Wang J, Guan W, Gjesteby LA, et al
   Integrated platform for multiscale molecular imaging and phenotyping of the human brain.
   Science. 2024;384:eadh9979.
   PubMed     Abstract available
   
   
   
2. COUZIN-FRANKEL J
   New Alzheimer's drug clears FDA advisory vote despite unknowns.
   Science. 2024;384:1164-1165.
   PubMed     Abstract available
   
   
   
3. PILLER C
   Authors move to retract discredited Alzheimer's study.
   Science. 2024;384:1055.
   PubMed     Abstract available
   
   
   May 2024
4. PRINCEN K, Van Dooren T, van Gorsel M, Louros N, et al
   Pharmacological modulation of septins restores calcium homeostasis and is neuroprotective in models of Alzheimer's disease.
   Science. 2024;384:eadd6260.
   PubMed     Abstract available
   
   
   
5. TOPOL EJ
   Medical forecasting.
   Science. 2024;384:eadp7977.
   PubMed     Abstract available
   
   
   March 2024
6. PILLER C
   'Damning' FDA inspection report undermines Alzheimer's drug.
   Science. 2024;383:1165-1166.
   PubMed     Abstract available
   
   
   December 2023
7. GOLDE TE, Levey AI
   Immunotherapies for Alzheimer's disease.
   Science. 2023;382:1242-1244.
   PubMed     Abstract available
   
   
   November 2023
8. PILLER C
   Brain games?
   Science. 2023;382:754-759.
   PubMed     Abstract available
   
   
   October 2023
9. PILLER C
   Probe of Alzheimer's studies finds 'egregious misconduct'.
   Science. 2023;382:251-252.
   PubMed     Abstract available
   
   
   September 2023
10. BALUSU S, Horre K, Thrupp N, Craessaerts K, et al
    MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer's disease.
    Science. 2023;381:1176-1182.
    PubMed     Abstract available
    
    
    
11. SIRKIS DW, Yokoyama JS
    Role for cell death pathway in Alzheimer's disease.
    Science. 2023;381:1156-1157.
    PubMed     Abstract available
    
    
    
12. AGUZZI A, Kampmann M
    Neurodegeneration enters the era of functional genomics.
    Science. 2023;381:eadk5693.
    PubMed     Abstract available
    
    
    August 2023
13. COUZIN-FRANKEL J
    Side effects loom over Alzheimer's drugs.
    Science. 2023;381:466-467.
    PubMed     Abstract available
    
    
    July 2023
14. ZHANG ZY, Harischandra DS, Wang R, Ghaisas S, et al
    TRIM11 protects against tauopathies and is down-regulated in Alzheimer's disease.
    Science. 2023;381:eadd6696.
    PubMed     Abstract available
    
    
    May 2023
15. TRAVIS J
    Latest Alzheimer's antibody is 'not a miracle drug'.
    Science. 2023;380:571.
    PubMed     Abstract available
    
    
    April 2023
16. PILLER C
    Report on trial death stokes Alzheimer's drug fears.
    Science. 2023;380:122-123.
    PubMed     Abstract available
    
    
    
17. COUZIN-FRANKEL J
    Promising Alzheimer's therapies shrink brains.
    Science. 2023;380:19.
    PubMed     Abstract available
    
    
    January 2023
18. COUZIN-FRANKEL J
    Alzheimer's drug approval gets a mixed reception.
    Science. 2023;379:126-127.
    PubMed     Abstract available
    
    
    December 2022
19. COUZIN-FRANKEL J, Piller C
    Alzheimer's drug stirs excitement-and concerns.
    Science. 2022;378:1030-1031.
    PubMed     Abstract available
    
    
    November 2022
20. PILLER C
    Whistleblower finds possible misconduct in his own papers.
    Science. 2022;378:694-695.
    PubMed     Abstract available
    
    
    
21. ENDO F, Kasai A, Soto JS, Yu X, et al
    Molecular basis of astrocyte diversity and morphology across the CNS in health and disease.
    Science. 2022;378:eadc9020.
    PubMed     Abstract available
    
    
    September 2022
22. HOFFMANN HM
    Boosting cognition with a hormone.
    Science. 2022;377:1042-1043.
    PubMed     Abstract available
    
    
    August 2022
23. ASHE KH
    Alzheimer's target still viable but untested.
    Science. 2022;377:935.
    PubMed    
    
    
    
24. SELKOE D, Cummings J
    News story miscasts Alzheimer's science.
    Science. 2022;377:934-935.
    PubMed    
    
    
    
25. COOPER YA, Teyssier N, Drager NM, Guo Q, et al
    Functional regulatory variants implicate distinct transcriptional networks in dementia.
    Science. 2022;377:eabi8654.
    PubMed     Abstract available
    
    
    July 2022
26. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
27. PILLER C
    Research backing experimental Alzheimer's drug was first target of suspicion.
    Science. 2022;377:363.
    PubMed    
    
    
    
28. PILLER C
    Blots on a field?
    Science. 2022;377:358-363.
    PubMed     Abstract available
    
    
    
29. ZHOU X, Sumrow L, Tashiro K, Sutherland L, et al
    Mutations linked to neurological disease enhance self-association of low-complexity protein sequences.
    Science. 2022;377:eabn5582.
    PubMed     Abstract available
    
    
    January 2022
30. YANG Y, Arseni D, Zhang W, Huang M, et al
    Cryo-EM structures of amyloid-beta 42 filaments from human brains.
    Science. 2022;375:167-172.
    PubMed     Abstract available
    
    
    December 2021
31. LESLIE M
    Blood condition may guard against Alzheimer's.
    Science. 2021;374:1425.
    PubMed     Abstract available
    
    
    October 2021
32. SELKOE DJ
    Alzheimer's drugs: Does reducing amyloid work?-Response.
    Science. 2021;374:545-546.
    PubMed    
    
    
    
33. THAMBISETTY M, Howard R, Glymour MM, Schneider LS, et al
    Alzheimer's drugs: Does reducing amyloid work?
    Science. 2021;374:544-545.
    PubMed    
    
    
    
34. SPIRES-JONES T
    Toward a holistic model of Alzheimer'sHow Not to Study a Disease: The Story of Alzheimer's Karl Herrup MIT Press, 2021. 272 pp.
    Science. 2021;374:267.
    PubMed     Abstract available
    
    
    August 2021
35. BLENNOW K
    Phenotyping Alzheimer's disease with blood tests.
    Science. 2021;373:626-628.
    PubMed    
    
    
    
36. SELKOE DJ
    Treatments for Alzheimer's disease emerge.
    Science. 2021;373:624-626.
    PubMed    
    
    
    July 2021
37. SERVICK K
    Alzheimer's drug approval spotlights blood tests.
    Science. 2021;373:373-374.
    PubMed    
    
    
    June 2021
38. SERVICK K
    Alzheimer's drug approved despite murky results.
    Science. 2021;372:1141.
    PubMed    
    
    
    December 2020
39. NAKAMURA T, Oh CK, Liao L, Zhang X, et al
    Noncanonical transnitrosylation network contributes to synapse loss in Alzheimer's disease.
    Science. 2020 Dec 3. pii: science.aaw0843. doi: 10.1126/science.aaw0843.
    PubMed     Abstract available
    
    
    November 2020
40. DARWICH NF, Phan JM, Kim B, Suh E, et al
    Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau.
    Science. 2020;370.
    PubMed     Abstract available
    
    
    October 2020
41. BARTELS T, De Schepper S, Hong S
    Microglia modulate neurodegeneration in Alzheimer's and Parkinson's diseases.
    Science. 2020;370:66-69.
    PubMed     Abstract available
    
    
    
42. SIERKSMA A, Escott-Price V, De Strooper B
    Translating genetic risk of Alzheimer's disease into mechanistic insight and drug targets.
    Science. 2020;370:61-66.
    PubMed     Abstract available
    
    
    
43. NEDERGAARD M, Goldman SA
    Glymphatic failure as a final common pathway to dementia.
    Science. 2020;370:50-56.
    PubMed     Abstract available
    
    
    August 2020
44. SUZUKI K, Elegheert J, Song I, Sasakura H, et al
    A synthetic synaptic organizer protein restores glutamatergic neuronal circuits.
    Science. 2020;369.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge.